Identifying TNFSF4low-MSCs superiorly treating idiopathic pulmonary fibrosis through Tregs differentiation modulation
Our study involved collecting 10 mL of peripheral blood from idiopathic pulmonary fibrosis patients, and the Medical Ethics Committee of Nanjing Drum Tower Hospital approved our study protocol with the approval number 2023-675-01.
Authors
- Bin Wang (ORCID: https://orcid.org/0000-0003-3981-8849)
- Liudi Wang
- Yirui Feng
- Yaping Wang (ORCID: https://orcid.org/0000-0003-2712-6220)
- Hui Yang (ORCID: https://orcid.org/0000-0002-3938-9530)
- Qing Yi
- Yuanyuan Xie (ORCID: https://orcid.org/0000-0002-1019-5070)
- Yingwei Zhang (ORCID: https://orcid.org/0000-0002-5705-9578)
- Yue Jiang (ORCID: https://orcid.org/0000-0002-9427-6627)
- Congwang Xu
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Traditional Chinese Medicine Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2025-04-20
- DOI
- https://doi.org/10.1186/s13287-025-04313-6
- Citations
- 4
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- National Natural Science Foundation of China